~ Higher Urinary Melatonin Level Associated with Lower Risk of Breast Cancer
A report published in the July 20 2005 issue of the Journal of the National Cancer Institute (http://jncicancerspectrum.oxfordjournals.org/) revealed a correlation between greater levels of a metabolite of melatonin in the urine and a lowered risk of invasive breast cancer in women. The metabolite, 6- sulphatoxymelatonin, is highly correlated with blood and salivary melatonin levels.
Eva S. Schernhammer and Susan E. Hankinson of Harvard University evaluated 438 participants in the Nursesí Health Study II, which enrolled 116,671 female nurses between the ages of 25 and 42 in 1989. The current study compared 147 women with invasive breast cancer and 291 matched controls who had agreed to participate in a substudy in which blood and urine samples were collected. First morning urine samples were used for 6-sulphatoxymelatonin measurement.
Drs Shernhammer and Hankinson found a strong inverse correlation between the risk of invasive breast cancer and urinary melatonin levels. Women whose melatonin levels were in the highest one-fourth of participants experienced a 41 percent lower risk of invasive breast cancer than those whose levels were in the lowest fourth. Those whose melatonin levels placed them in the second and third quarters also experienced a risk reduction compared to women in the lowest fourth. When women who worked at night (a factor that has been linked with an elevated risk of breast cancer) were excluded from the analysis, the risk remained basically the same.
The authors summarize their findings by stating that melatonin secretion may play an important role in breast cancer development. This study contributes to a growing body of evidence concerning the role that decreased melatonin production plays in breast cancer risk.
Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.
While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.